CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Cryoablation +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02085941
NCT02085941N/ACompleted
CompareCT.gov

Image-guided Cryoablation of Head, Neck and Spine Tumors

Dana-Farber Cancer Institute·interventional·Posted Mar 13, 2014·Updated Aug 15, 2022

In Brief

A clinical study evaluating Cryoablation and Biopsy for Head and Neck Neoplasms and Malignant Neoplasm of Vertebral Column. Completed, enrolled 30 participants across 2 sites.

Detailed Summary

This research study is evaluating a procedure called cryoablation (the removal of diseased tissue using extreme freezing temperatures) as a possible treatment for head, neck and spine tumors.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHead and Neck Neoplasms, Malignant Neoplasm of Vertebral Column
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 13, 2014
Enrollment StartFeb 1, 2015
Primary CompletionJul 1, 2021
TodayJul 2, 2026
Enrollment to primary: 6.4 yearsPosted 12.3 years ago

Interventions

Cryoablationdevice

Cryoablation using 17G Galil cryoprobe

Biopsydevice

Biopsy using 18G Temno core biopsy needle